A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity

Jörg Täubel, Alessandro Mazzetti, Georg Ferber, William Burch, Sara Fernandes, Avani Patel, Christopher S. Spencer, Anne Freier, Claus Graff, Jørgen K. Kanters, John Camm

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalClinical Pharmacology in Drug Development
Volume10
Issue number6
Pages (from-to)572-581
Number of pages10
DOIs
Publication statusPublished - Jun 2021

Keywords

  • androgen receptor inhibitor
  • androgenetic alopecia
  • antiandrogen
  • cardiac safety
  • cortexolone 17α-propionate
  • QT interval

Fingerprint

Dive into the research topics of 'A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity'. Together they form a unique fingerprint.

Cite this